Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-015118
Filing Date
2022-08-05
Accepted
2022-08-05 16:06:43
Documents
73
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fmtx-20220630.htm   iXBRL 10-Q 2854301
2 EX-10.1 fmtx-ex10_1.htm EX-10.1 39319
3 EX-31.1 fmtx-ex31_1.htm EX-31.1 12648
4 EX-31.2 fmtx-ex31_2.htm EX-31.2 12839
5 EX-32.1 fmtx-ex32_1.htm EX-32.1 10094
  Complete submission text file 0000950170-22-015118.txt   9495215

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fmtx-20220630.xsd EX-101.SCH 76916
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fmtx-20220630_pre.xml EX-101.PRE 404451
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fmtx-20220630_def.xml EX-101.DEF 231194
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fmtx-20220630_lab.xml EX-101.LAB 525354
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fmtx-20220630_cal.xml EX-101.CAL 54142
67 EXTRACTED XBRL INSTANCE DOCUMENT fmtx-20220630_htm.xml XML 1737196
Mailing Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472
Business Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Filer) CIK: 0001538927 (see all company filings)

EIN.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39333 | Film No.: 221140807
SIC: 2836 Biological Products, (No Diagnostic Substances)